Clexane and Diprivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clexane (enoxaparin sodium) and Diprivan (propofol). Common drug interactions include coma among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Clexane and Diprivan. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

On Jul, 10, 2026

15 people who take Clexane and Diprivan together, and have interactions are studied.

What are the common drug interactions of Clexane and Diprivan, by gender? *:

female:

Coma (state of unconsciousness lasting more than six hours)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Blood pressure increased
Cerebral infarction (less blood supply to brain resulting tissue damage)
Oliguria (not enough urine)
Renal impairment (severely reduced kidney function)

male:

Alanine aminotransferase increased
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Ventricular fibrillation (abnormally irregular heart rhythm)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Coma (state of unconsciousness lasting more than six hours)
Dyskinesia (abnormality or impairment of voluntary movement)
Hepatic failure (liver failure)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Impaired gastric emptying

What are the common drug interactions of Clexane and Diprivan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Gamma-glutamyltransferase increased

20-29:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Leukopenia (less number of white blood cells in blood)

30-39:

n/a

40-49:

Coma (state of unconsciousness lasting more than six hours)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Cerebral infarction (less blood supply to brain resulting tissue damage)

50-59:

n/a

60+:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Coma (state of unconsciousness lasting more than six hours)
Dyskinesia (abnormality or impairment of voluntary movement)
Hepatic failure (liver failure)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Impaired gastric emptying
Oliguria (not enough urine)
Pancreatitis (inflammation of pancreas)
Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 40.00%
Anaesthesia: 5 people, 33.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 33.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 20.00%
Pneumonia: 3 people, 20.00%
Pain: 3 people, 20.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 20.00%
Nausea (feeling of having an urge to vomit): 3 people, 20.00%
Fever: 3 people, 20.00%
Back Pain: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and Diprivan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously